(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.12%) $82.53
(0.84%) $2.05
(-0.60%) $2 343.60
(-1.16%) $27.34
(-0.07%) $960.80
(0.08%) $0.933
(0.11%) $10.99
(0.02%) $0.796
(0.01%) $93.31
0.00% $ 18.00
Live Chart Being Loaded With Signals
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others...
Stats | |
---|---|
Dzisiejszy wolumen | 465.00 |
Średni wolumen | 493 725 |
Kapitalizacja rynkowa | 0.00 |
Last Dividend | $0.108 ( 2022-03-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.819 (4.55%) |
Wolumen Korelacja
Olympus Corporation Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Olympus Corporation Korelacja - Waluta/Towar
Olympus Corporation Finanse
Annual | 2022 |
Przychody: | $868.87B |
Zysk brutto: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2022 |
Przychody: | $868.87B |
Zysk brutto: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2021 |
Przychody: | $730.54B |
Zysk brutto: | $459.53B (62.90 %) |
EPS: | $10.05 |
FY | 2020 |
Przychody: | $797.41B |
Zysk brutto: | $499.57B (62.65 %) |
EPS: | $39.37 |
Financial Reports:
No articles found.
Olympus Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0156 | 2003-03-26 |
Last Dividend | $0.108 | 2022-03-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | $1.329 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.62 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.84 | |
Div. Directional Score | 7.24 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PNGAY | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
EGIEY | Ex Dividend Knight | 2023-08-31 | Quarterly | 0 | 0.00% | |
UEPEO | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
KGFHY | Ex Dividend Knight | 2023-10-12 | Annually | 0 | 0.00% | |
BZLFY | Ex Dividend Knight | 2023-11-16 | Semi-Annually | 0 | 0.00% | |
SAFRY | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
FMBL | Ex Dividend Junior | 2023-09-14 | Quarterly | 0 | 0.00% | |
WRTBY | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
MCHB | Ex Dividend Knight | 2023-08-09 | Annually | 0 | 0.00% | |
CNAF | Ex Dividend Knight | 2023-08-24 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.173 | 1.500 | 6.54 | 9.81 | [0 - 0.5] |
returnOnAssetsTTM | 0.0558 | 1.200 | 8.14 | 9.77 | [0 - 0.3] |
returnOnEquityTTM | 0.125 | 1.500 | 9.73 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.83 | 3.86 | [1 - 3] |
quickRatioTTM | 0.544 | 0.800 | -1.503 | -1.203 | [0.8 - 2.5] |
cashRatioTTM | 0.495 | 1.500 | 8.36 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.253 | -1.500 | 5.78 | -8.67 | [0 - 0.6] |
interestCoverageTTM | 35.39 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.584 | -1.500 | 7.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.686 | 1.000 | 1.908 | 1.908 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.236 | 1.000 | 7.28 | 7.28 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.232 | 1.000 | 9.82 | 9.82 | [0.2 - 2] |
assetTurnoverTTM | 0.323 | 0.800 | -1.183 | -0.946 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.41 | 1.000 | 5.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.125 | 2.50 | 9.82 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.000360 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.182 | 1.000 | 7.95 | 0 | [0.1 - 0.5] |
Total Score | 3.84 |
Olympus Corporation
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej